Asian guidelines for UTIs & STIs UTI section: Complicated UTIs with neurogenic bladder

J Infect Chemother. 2022 Jan;28(1):6-9. doi: 10.1016/j.jiac.2021.10.010. Epub 2021 Oct 23.


Epidemiology and pathogenesis: Urinary tract infection (UTI) in patients with neurogenic bladder causes significant morbidity and mortality.

Diagnosis: UTI in neurogenic bladder causes atypical symptomatology. Urine tests are pivotal in confirming or excluding UTI, and in guiding appropriate antibiotic treatment.

Treatment: 1. Symptomatic UTI warrants appropriate antibiotic treatment with reference to culture results and local antibiotic resistance patterns. Asymptomatic bacteriuria should not be treated, and antibiotic prophylaxis is generally not recommended.2. Adequate bladder drainage is essential in reducing the occurrence of urinary tract infections.3. Recurrent UTI in neurogenic bladder may necessitate the treatment of neurogenic detrusor overactivity and the restoration of low bladder pressure during bladder storage and voiding by drugs or surgery.

Keywords: AAUS Guideline; Asian guidelines for UTIs & STIs; Complicated urinary tract infection; Neurogenic bladder.

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Bacteriuria* / drug therapy
  • Humans
  • Sexually Transmitted Diseases*
  • Urinary Bladder, Neurogenic*
  • Urinary Tract Infections* / drug therapy


  • Anti-Bacterial Agents